Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection.
Elias B ChahineSpencer H DurhamPublished in: The Annals of pharmacotherapy (2020)
IBA provides a needed treatment option to achieve and maintain viral suppression in heavily treatment-experienced adults with MDR HIV-1 infection.
Keyphrases